Clinical Trial Update: CC486-CHOP in Patients With Previously Untreated Peripheral T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CC486-CHOP in patients with previously untreated peripheral T-cell lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• CC486-CHOP

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Previously Untreated Peripheral T-cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2021-05-20